Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-06-03

Clinical Trial Update: Pericapsular Nerve Group Block (PENG) for Hip Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial of Pericapsular Nerve Group (PENG) block for hip surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pericapsular Nerve Group block (PENG) (pericapsular nerve group block)

Snippet

Sponsor: University of California, San Diego | Conditions: Hip Arthropathy, Postoperative Pain, Acute | Phase 4 | Status: WITHDRAWN